Status:
ACTIVE_NOT_RECRUITING
DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS
Lead Sponsor:
Mahmut Gumus
Conditions:
Non Small Cell Lung Cancer
Small-cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Observational, prospective clinical research, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCL...
Detailed Description
In Turkey, non-small cell lung cancer (NSCLC) is the most common cause of cancer-related death in men and one of the most common causes of cancer-related deaths in women. Because of the heterogeneity ...
Eligibility Criteria
Inclusion
- Patient histopathologically diagnosed with non-small cell lung cancer or small cell lung cancer
- Written informed consent no later than six weeks after start of first-line treatment
- Age ≥ 18 years
Exclusion
- Volunteers participating in a research program for non-small cell or small cell lung cancer that includes interventions outside of routine clinical trial
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT05254119
Start Date
December 1 2021
End Date
February 28 2025
Last Update
April 4 2024
Active Locations (39)
Enter a location and click search to find clinical trials sorted by distance.
1
Adana Başkent University Hospital
Adana, Turkey (Türkiye)
2
Adana City Training and Research Hospital
Adana, Turkey (Türkiye)
3
Ankara City Hospital (1)
Ankara, Turkey (Türkiye)
4
Ankara City Hospital (2)
Ankara, Turkey (Türkiye)